Figure 1.
Efficacy and complications of phacoemulsification combined with ECP
| Berke et al. | Yap et al. | Bolek et al. | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Duration of follow-up (months) | Postoperatively | 12 | 24 | 36 | 12 | 24 | 36 | 48 | 60 |
| Preop. IOP (mmHg) | 19.1 | 18.4 | 22.6 | ||||||
| Preop. N of IOP-lowering meds | 1.5 | 2.7 | - | ||||||
| Postop. IOP (mmHg) | 15.7 | 14.3 | 14.1 | 13.6 | 15.9 | 15.9 | 15.6 | 15.5 | 15.2 |
| Postop. N of IOP-lowering meds | 0.7 | 1.3 | 1.7 | 1.8 | - | - | - | - | - |
| IOP reduction (%) | 17.8 | 22.3 | 23.4 | 26.1 | 29.6 | 29.6 | 31.0 | 31.4 | 32.7 |
| N of IOP-lowering meds reduction (%) | 53.3 | 51.9 | 37.0 | 33.3 | - | - | - | - | - |
| Complications | There were no severe complications, and the rates of cystoid macular edema did not exceed those expected for a standard phacoemulsification in any patient. | Uveitis (6%), macular edema (2%), IOP spikes (1%), and corneal decompensation (1%). No episodes of hypotony or retinal detachment were reported. | Corneal edema (25.6%), IOP spikes (20.5%), intraocular lens dislocation (2.6%), uveitis (12.8%). No episodes of hypotony were reported. | ||||||
Efficacy and complications of ECP in patients undergoing PPV
| Gorovoy et al. [26] | Boyd et al. [27] | He et al. [28] | ||
|---|---|---|---|---|
| Duration of follow-up (months) | 1 | 3 | 12.2 | 15.2 |
| Preop. IOP (mmHg) | 26.3 | 20.3 | 46.3 | |
| Preop. N of IOP-lowering meds | 2.7 | 2.3 | 4.0 | |
| Postop. IOP (mmHg) | 17.9 | 16.9 | 14.6 | 18.5 |
| Postop. N of IOP-lowering meds | 1.3 | 1.3 | 2.0 | 1.0 |
| IOP reduction (%) | 31.9 | 35.7 | 28.1 | 60.0 |
| N of IOP-lowering meds reduction (%) | 51.9 | 51.9 | 13.0 | 75.0 |
| Complications | One patient developed hypotonia. Postoperative inflammation or discomfort did not exceed what was expected for a standard vitrectomy in any patient. | There were no ocular and systemic complications. | Postoperative inflammation or discomfort did not exceed what was expected for a standard vitrectomy in any patient. | |